Pharmaceuticals - Stevenage, England, United Kingdom
Immuno-inflammatory diseases, including asthma, atopic dermatitis and inflammatory bowel disease, result from a poorly controlled or overactive immune response. Affecting a large proportion of the population these diseases are characterised by an increase in chronic inflammation which, if left unchecked, over time will lead to organ damage and loss of function. These diseases are often associated with increased morbidity and/or mortality.Peptinnovate Ltd is a drug development company engaged in research and development of innovative new therapies, targeting a range of immuno–inflammatory diseases.We believe that our products have the ability to significantly advance the control and management of moderate to severe chronic inflammatory diseases, with the potential for diseases modification and remission.We are now entering the exciting phase of clinical development to prove safety and efficacy.
Outlook
Microsoft Office 365